October 26, 2015 | Chinese medical company Xizang Haisco Pharmaceutical Group (Haisco) has invested $10 million into Israeli medical device company, Endospan. As part of the deal, Haisco will have exclusive rights within China to distribute Endospan’s heart stents. Based in Herzliya, Endospan was founded by CEO Alon Shalev and CTO Rafi Benary, and has already raised $25 million, including financing from Sequoia Capital and the Accelmed Fund.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments